Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Inflammation Research
Published in: Inflammation Research 7/2011

01-07-2011 | Original Research Paper

Green tea polyphenols avert chronic inflammation-induced myocardial fibrosis of female rats

Authors: Chwan-Li Shen, Christina Samathanam, Owatha L. Tatum, Suzanne Graham, Christine Tubb, Jay J. Cao, Dale M. Dunn, Jia-Sheng Wang

Published in: Inflammation Research | Issue 7/2011

Login to get access

Abstract

Objective

Green tea proposes anti-inflammatory properties which may attenuate chronic inflammation-induced fibrosis of vessels. This study evaluated whether green tea polyphenols (GTP) can avert fibrosis or vascular disruption along with mechanisms in rats with chronic inflammation.

Treatments

Forty 3-month-old female rats were assigned to a 2 (placebo vs. lipopolysaccharide, administration) × 2 (no GTP vs. 0.5% GTP in drinking water) factorial design for 12 weeks.

Methods

Masson’s trichrome staining evaluated myocardial fibrosis in coronary vessels and surrounding myocardium. Whole blood specimens were counted for differentials. Spleen tumor necrosis factor-α (TNF-α) mRNA expression was determined by real-time RT–PCR. Data were analyzed by two-way analysis of variance (ANOVA) followed by mean separation procedures.

Results

After 12 weeks, lipopolysaccharide administration induced myocardial fibrosis in vessels and surrounding myocardium, spleen TNF-α mRNA expression, and leukocytes, while GTP supplementation in drinking water significantly averted such observation.

Conclusions

GTP attenuates myocardial fibrosis through a suppression of chronic inflammation and innate immune responses.
Literature
1.
Pedersen BK. The anti-inflammatory effect of exercise: its role in diabetes and cardiovascular disease control. Essays Biochem. 2006;42:105–17.PubMedCrossRef
2.
Laurat E, Poirier B, Tupin E, Caligiuri G, Hansson GK, Bariéty J, Nicoletti. In vivo downregulation of T helper cell 1 immune responses reduces atherogenesis in apolipoprotein E-knockout mice. Circulation. 2001;104:197–202.
3.
Regensteiner JG, Hiatt WR. Current medical therapies for patients with peripheral arterial disease: a critical review. Am J Med. 2002;112:49–57.PubMedCrossRef
4.
Tang J, Raines EW. Are suppressors of cytokine signaling proteins recently identified in atherosclerosis possible therapeutic targets? Trends Cardiovasc Med. 2005;15:243–9.PubMedCrossRef
5.
Kuriyama S, Shimazu T, Ohmori K, Kikuchi N, Nakaya N, Nishino Y, Tsubono Y, Tsuji I. Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan. JAMA. 2006;296(10):1255–65.PubMedCrossRef
6.
Stangl V, Dreger H, Stangl K, Lorenz M. Molecular targets of tea polyphenols in the cardiovascular system. Cardiovasc Res. 2007;73(2):348–58.PubMedCrossRef
7.
Sueoka N, Suganuma M, Sueoka E, Okabe S, Matsuyama S, Imai K, Nakachi K, Fujiki H. A new function of green tea: prevention of lifestyle-related diseases. Ann N Y Acad Sci. 2001;928:274–80. Review.
8.
Moore RJ, Jackson KG, Minihane AM. Green tea (Camellia sinensis) catechins and vascular function. Br J Nutr. 2009;102(120):1790–802.PubMedCrossRef
9.
Mineharu Y, Koizumi A, Wada Y, Iso H, Watanabe Y, Date C, Yamamoto A, Kikuchi S, Inaba Y, Toyoshima H, Kondo T, Tamakoshi A, and the JACC study group. Coffee, green tea, black tea and oolong tea consumption and risk of mortality from cardiovascular disease in Japanese men and women. J Epidemiol Community Health 2010. (Epub ahead of print).
10.
Suganuma M, Sueoka E, Sueoka N, Okabe S, Fujiki H. Mechanisms of cancer prevention by tea polyphenols based on inhibition of TNF-alpha expression. Biofactors. 2000;13(1–4):67–72.PubMedCrossRef
11.
Shen CL, Yeh JK, Samathanam C, Cao JJ, Stoecker BJ, Dagda RY, Chyu MC, Dunn DM, Wang JS. Green tea polyphenols attenuate deterioration of bone microarchitecture in female rats with systemic chronic inflammation. Osteoporos Int 2010. (Epub ahead of print).
12.
Wang JS, Luo H, Wang P, Tang L, Yu J, Huang T, Cox S, Gao W. Validation of green tea polyphenol biomarkers in a phase II human intervention trial. Food Chem Toxicol. 2008;46(1):232–40.PubMedCrossRef
13.
Shen CL, Yeh JK, Cao JJ, Tatum OL, Dagda RY, Wang JS. Green tea polyphenols mitigate bone loss of female rats in a chronic inflammation-induced bone loss model. J Nutr Biochem. 2010;21(10):968–74.PubMedCrossRef
14.
Shen CL, Wang P, Guerrieri J, Yeh JK, Wang JS. Protective effect of green tea polyphenols on bone loss in middle-aged female rats. Osteoporos Int. 2008;19(7):979–90.PubMedCrossRef
15.
Smith BJ, Lerner MR, Bu SY, Lucas EA, Hanas JS, Lightfoot SA, Postier RG, Bronze MS, Brackett DJ. Systemic bone loss and induction of coronary vessel disease in a rat model of chronic inflammation. Bone. 2006;38(3):378–86.PubMedCrossRef
16.
Hori M, Nishida K. Oxidative stress and left ventricular remodelling after myocardial infarction. Cardiovasc Res 2009;81(3):457–64. (Review).
17.
Li R, Huang YG, Fang D, Le WD. (−)-Epigallocatechin gallate inhibits lipopolysaccharide-induced microglial activation and protects against inflammation-mediated dopaminergic neuronal injury. J Neurosci Res. 2004;78(5):723–31.PubMedCrossRef
18.
He P, Noda Y, Sugiyama K. Green tea suppresses lipopolysaccharide-induced liver injury in d-galactosamine-sensitized rats. J Nutr. 2001;131(5):1560–7.PubMed
19.
Hong Byun E, Fujimura Y, Yamada K, Tachibana H. TLR4 signaling inhibitory pathway induced by green tea polyphenol epigallocatechin-3-gallate through 67-kDa laminin receptor. J Immunol. 2010;185(1):33–45.PubMedCrossRef
20.
Koeberle A, Bauer J, Verhoff M, Hoffmann M, Northoff H. Werz O. Green tea epigallocatechin-3-gallate inhibits microsomal prostaglandin E(2) synthase-1. Biochem Biophys Res Commun. 2009;388(2):350–4.PubMedCrossRef
21.
Smith BJ, Lightfoot SA, Lerner MR, Denson KD, Morgan DL, Hanas JS, Bronze MS, Postier RG, Brackett DJ. Induction of cardiovascular pathology in a novel model of low-grade chronic inflammation. Cardiovasc Pathol. 2009;18(1):1–10.PubMedCrossRef
22.
Ramesh E, Geraldine P, Thomas PA. Regulatory effect of epigallocatechin gallate on the expression of C-reactive protein and other inflammation markers in an experimental model of atherosclerosis. Chem Biol Interact. 2010;183(1):125–32.PubMedCrossRef
23.
Kim IB, Kim DY, Lee SJ, Sun MJ, Lee MS, Li H, Cho JJ, Park CS. Inhibition of IL-8 production by green tea polyphenols in human nasal fibroblasts and A549 epithelial cells. Bio Pharm Bull. 2006;29(6):1120–5.CrossRef
24.
Dona M, Dell’Aica I, Calabrese F, Benelli R, Morini M, Albini A, Garbisa S. Neutrophil restraint by green tea: inhibition of inflammation associated angiogenesis and pulmonary fibrosis. J Immunol. 2003;170(8):4335–41.PubMed
25.
Hofbauer R, Frass M, Gmeiner B, Handler S, Speiser W, Kapiotis S. The green tea extract epigallocatechin gallate is able to reduce neutrophil transmigration through monolayers of endothelial cells. Wien Klin Wochenschr. 1999;111(7):278–82.PubMed
26.
Ludwig A, Lorenz M, Grimbo N, Steinle F, Meiners S, Bartsch C, Stangl K, Baumann G, Stangl V. The tea flavonoid epigallocatechin-3-gallate reduces cytokine-induced VCAM-1 expression and monocyte adhesion to endothelial cells. Biochem Biophys Res Commun. 2004;316(3):659–65.PubMedCrossRef
27.
Chen HI, Hsieh SY, Yang FL, Hsu YH, Lin CC. Exercise training attenuates septic responses in conscious rats. Med Sci Sports Exerc. 2007;39(3):435–42.PubMedCrossRef
28.
Liese AM, Siddiqi MQ, Siegel JH, Denny T, Spolarics Z. Augmented TNF-alpha and IL-10 production by primed human monocytes following interaction with oxidatively modified autologous erythrocytes. J Leukoc Biol. 2001;70(2):289–96.PubMed
29.
Starzyk D, Korbut R, Grygelwski RJ. The role of nitric oxide in regulation of deformability of red blood cells in acute phase of endotoxaemia in rats. J Physiol Pharmacol. 1997;48(4):731–5.PubMed
30.
Cheng HC, Chan CM, Tsay HS, Liang HJ, Liang YC, Liu DZ. Improving effects of epigallocatechin-3-gallate on hemorheological abnormalities of aging guinea pigs. Circ J. 2007;71(4):597–603.PubMedCrossRef
31.
Droke EA, Hager KA, Lerner MR, Lightfoot SA, Stoecker BJ, Brackett DJ, Smith BJ. Soy isoflavones avert chronic inflammation-induced bone loss and vascular disease. J Inflamm (Lond). 2007;4:17.CrossRef
Metadata
Title
Green tea polyphenols avert chronic inflammation-induced myocardial fibrosis of female rats
Authors
Chwan-Li Shen
Christina Samathanam
Owatha L. Tatum
Suzanne Graham
Christine Tubb
Jay J. Cao
Dale M. Dunn
Jia-Sheng Wang
Publication date
01-07-2011
Publisher
SP Birkhäuser Verlag Basel
Published in
Inflammation Research / Issue 7/2011
Print ISSN: 1023-3830
Electronic ISSN: 1420-908X
DOI
https://doi.org/10.1007/s00011-011-0320-y

Other articles of this Issue 7/2011

Inflammation Research 7/2011 Go to the issue

Original Research Paper

Anti-inflammatory properties of N-acetylcysteine on lipopolysaccharide-activated macrophages

Original Research Paper

Dectin-1 and NOD2 mediate cathepsin activation in zymosan-induced arthritis in mice

Original Research Paper

Expression of VLA-4 molecule in PBMC from patients with hemorrhagic fever with renal syndrome

Original Research Paper

Role of CFTR expressed by neutrophils in modulating acute lung inflammation and injury in mice

Original Research Paper

Prostaglandin I2 analogues suppress TNF-α expression in human monocytes via mitogen-activated protein kinase pathway

Original Research Paper

Inhibition of phosphodiesterase 9A reduces cytokine-stimulated in vitro adhesion of neutrophils from sickle cell anemia individuals
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits